NCT00001244
- Conditions
- Agammaglobulinemia, Blau Syndrome, Blau syndrome, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Agammaglobulinemia
Explore clinical trials studying Agammaglobulinemia. Study availability and eligibility vary by location and protocol.
30 public trials
8 recruiting studies
Agammaglobulinemia trial results
Recruiting
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
NCT07220915
- Conditions
- Agammaglobulinemia, Autoimmune Conditions, Blood Protein Disorders, +9 more
- Locations
-
- Perseverance Research Center, Phoenix Neurological Associates Scottsdale, Arizona, United States
- UMHAT Sveti Georgi EAD Plovdiv, Bulgaria
- P. Stradins Clinical University Hospital Riga, Latvia
- Riga East Clinical University Hospital Riga, Latvia
Recruiting
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
NCT05357781
- Conditions
- Agammaglobulinemia, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
- Locations
-
- University Hospital of Bern Inselspital Bern, Canton of Bern, Switzerland
- Conditions
- Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
- Locations
-
- GC2202 Study Site 115 Huntington Park, California, United States
- GC2202 Study Site 103 St. Petersburg, Florida, United States
- GC2202 Study Site 111 Bethesda, Maryland, United States
- GC2202 Study Site 109 Greenville, North Carolina, United States
Recruiting
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity) Commack, New York, United States
NCT06954441
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +7 more
- Locations
-
- IMIP Centro de Pesquisa Recife, Pernanbuco, Brazil
Recruiting
IVIG vs SCIG in CIDP
NCT05584631
- Conditions
- Agammaglobulinemia, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +28 more
- Locations
-
- Rutgers, The State University of New Jersey Clinical Research Center New Brunswick, New Jersey, United States
NCT05678621
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Haematological Malignancy, +16 more
- Locations
-
- Canberra Hospital Garran, Australian Capital Territory, Australia
- Concord Hospital Concord, New South Wales, Australia
- Royal North Shore St Leonards, New South Wales, Australia
- Monash Medical Centre Clayton, Victoria, Australia
Not yet recruiting
Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
NCT07775313
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, DNA Virus Infections, +19 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, not recruiting
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)
NCT04944979
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
- Locations
-
- Benioff Children's Hospital - Mission Bay San Francisco, California, United States
- IMMUNOe Health and Research Centers Centennial, Colorado, United States
- Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
- Velocity Clinical Research - MedPharmics - Lafayette Lafayette, Louisiana, United States